Cuban Says AI Could Expose Healthcare Contract Terms
The billionaire investor argued that AI contract review could help employers challenge the complex deals that drive healthcare costs.
Updated on Nov. 1, 2026 in Healthcare
Live Poll
Do you think healthcare costs will get lower in the next few years?
Mark Cuban said on a recent episode of the a16z podcast that AI could analyze healthcare contracts before employers sign them, highlighting problematic terms and helping them decide what to negotiate. He pointed to a 1,335-page contract between the city of Dallas and a pharmacy benefit manager as an example of how difficult such agreements are to parse.
Why it matters
Healthcare companies are locked into complex contracts that are hard to understand or negotiate, and Cuban argued the system is fundamentally inefficient. For U.S. employers covering large workforces, tools that surface hidden terms could shift negotiating leverage over healthcare spending.
A single city-PBM contract runs 1,335 pages, and UnitedHealth Group, which has more than 3,000 subsidiaries, moves roughly $150 billion through intercompany transfers each year. Cuban's projection that 67% of employers covering more than 160 million Americans could use AI contract review was offered as a hypothetical, and the source does not indicate how many employers currently do so.
The players
Mark Cuban
Billionaire entrepreneur and investor known for his outspoken commentary on the U.S. healthcare system and pharmacy benefit managers.
a16z podcast
The Andreessen Horowitz podcast, a technology-focused interview program where Cuban made the remarks.
The details
Cuban described employers asking an AI agent to examine a contract, flag problematic terms, explain their meaning, and advise on what to negotiate. He also said AI could drive personalized drug design toward near-zero cost, citing manufacturers like Cost Plus Drugs that already use AI, robotics, and modular production pods.
Timeline
• November 1, 2026: Benzinga published its report on Cuban's remarks.
Industry Dynamics
Cuban's argument follows the approach of Cost Plus Drugs, which already uses AI, robotics, and modular production pods to make medicines in smaller facilities. His contract-review proposal extends that push for transparency into the pharmacy benefit manager contracts that have long shaped U.S. drug spending.
Employers weighing pharmacy benefit contracts could one day use AI to catch unfavorable terms before signing, which could affect the premiums and plan costs their workers pay. The proposal remains a forecast, so no immediate change to coverage or prices is reported.
The takeaway
Employers that review contracts carefully before signing may be better positioned to negotiate healthcare costs, and AI tools could make that scrutiny more accessible. Readers should watch whether employers adopt such tools and how pharmacy benefit contracts change in response.
Further reading
Explore more on the Healthcare industry beat for context on how contracts and pricing shape U.S. care costs.
Source note: This article includes information reported by Benzinga.
Live Poll
Do you think healthcare costs will get lower in the next few years?
